FDA Inspection
Nancy L. Bartlett, MDNancy L. Bartlett, MD – FDA Inspection, Aug 26, 2016
Record Details
This FDA Inspection record concerns Nancy L. Bartlett, MD, with an inspection on August 26, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Nancy L. Bartlett, MD
- Inspection Date
- August 26, 2016
- Product Type
- Drugs
View Company Profile
ID · 243e779c-122c-49e5-b8ad-a05f340d1263
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 983028
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Nancy L. Bartlett, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| June 28, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 20, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Nancy L. Bartlett, MD
- FDA Inspection 1175659 - 2022-06-28
- FDA Inspection 950341 - 2015-11-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.